| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.9B | $8.2B | $8.2B | $8.4B | $8.2B | $2.0B | $1.6B | $5.8B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.9B | $0.1B | $1.0B | $1.7B | $3.1B | $0.7B | $0.4B | $0.3B |
| EPS (Basic) | $2.39 | $0.26 | $3.00 | $5.06 | $8.28 | $1.83 | $0.99 | $0.70 |
| EPS (Diluted) | $2.37 | $0.26 | $2.98 | $5.03 | $8.22 | $1.82 | $0.99 | $0.70 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $196.0B | $191.8B | $196.4B | $191.8B | $182.1B | $182.2B | $180.6B | $178.9B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $10.0B | $10.3B | $6.9B | $5.6B | $5.1B | $15.6B | $3.6B | $4.5B |
| Total Liabilities | $180.5B | $177.9B | $182.6B | $179.0B | $165.1B | $167.5B | $166.2B | $165.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $15.5B | $13.9B | $13.8B | $12.9B | $17.1B | $14.7B | $14.4B | $13.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $3.7B | $4.5B | $4.7B | $6.2B | $4.0B | $3.7B | $4.0B | $4.2B |
| Investing Cash Flow | $-5.3B | $5.0B | $-7.3B | $-17.3B | $-11.1B | $8.4B | $-3.8B | $-14.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.0B | $-5.6B | $3.8B | $11.6B | $-3.8B | $0.0B | $-1.5B | $10.7B |